By Dominic Chopping


Danish biotechnology company Bavarian Nordic A/S said Friday that the funding agreement with the Danish Ministry of Health to further advance the company's Covid-19 vaccine candidate, has now been approved by the Finance Committee of the Danish Parliament, thereby finally executing the agreement.


Write to Dominic Chopping at


(END) Dow Jones Newswires

September 24, 2021 05:14 ET (09:14 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.